Infant Bacterial Therapeutics IBT Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Margareta Hagman, was filed 13 May 2024.
Infant Bacterial Therapeutics IBT: what insiders have been doing
Infant Bacterial Therapeutics IBT is a listed company. Its insiders report their share dealings to Finansinspektionen. No insider at Infant Bacterial Therapeutics IBT has published a filing in the past twelve months. The most recent one dates from 13 May 2024.
The full history, which starts in 2018, counts 2 purchases against no sales.
Elsewhere in the same market, our signals recently picked up insider purchases at Dynavox Group AB and Rusta AB (publ). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Financial data
· cache
- 1,000 shares@ SEK 93.409835.9% of flowAktieISIN SE0010713958FI:csv-564c0af7d5013dde9556Canonical exit: 11 Aug 2024 (T+90)
- 1,470 shares@ SEK 95.00100.0% of flowISIN SE0010713958FI:csv-0f403a6873d713b01757Canonical exit: 1 May 2018 (T+90)
2 of 2 declarations
About Infant Bacterial Therapeutics IBT
Infant Bacterial Therapeutics IBT is a company focused on developing bacterial-based treatments for infants. It is listed on the XSTO exchange.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations